Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712770 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
ElectronicAdd to Basket
Live Chat Live Help Software for Website

The Future of Systems Biology: Emerging Technologies and their Impact on Drug Discovery, Development and Diagnostics

Business Insights, Sep 2005


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

'The Future of Systems Biology: Emerging Technologies and their Impact on Drug Discovery, Development and Diagnostics' is a new report which analyzes how systems biology can be used to cut R&D time and costs through improved target identification and lead quality, better elucidation of ADME/Tox profiles, as well as optimizing clinical trial efficiency. This report provides a detailed insight into this complex new process and how it can be used to drive research and development in a variety of biologically-based industries. The competitive landscape of systems biology assessed in this report is supported by case studies of leading companies, enabling you to learn from their experiences and avoid the potential pitfalls. The future of pharmaceuticals lies in combination therapies and more personalized therapeutics. This report will help you to maximize the cost and time saving benefits offered by biological systems in these areas to secure your frontline position in the marketplace.

Key Features:

- Detailed case studies of the pharmaceutical companies using systems biology to improve the drug discovery and development process.

- In-depth profiles on all major companies operating in systems biology, including patent information

- Detailed interviews with three thought leaders in systems biology

- Comprehensive listing of all major international initiatives in systems biology as well as key non-profit research centres

Key Findings

- Reductionist biology, which has been the traditional source of drug discovery, will not supply the solutions to complex diseases such as cancer and diabetes.

- Systems biology can provide the most benefit in improving lead optimization as well as providing better strategies for clinical trials.

- Systems biology offers the opportunity to study targets in an integrated network rather than in isolation.

- Roche uses in silico technologies in approximately 50% of its projects, mostly drugs in Phase II and Phase III clinical trials.





Customers who bought this item also bought

Proteomics - Technologies, Markets and Companies

Biomarkers - Technologies, Markets and Companies

Innovations in Bioinformatics: Emerging Tools for Drug Discovery and Development

Cell Therapy - Technologies, Markets and Companies

Proteomics - Global Strategic Business Report

Enabling Innovation: Drug Development Through Biomarker Validation and Qualification

Nanobiotechnology Applications, Markets and Companies

Cytogenetics - Technologies, Markets and Companies

Biomarkers: Discovery Techniques and Applications – A Global Market Overview

Systems Biology in Biotech and Pharma: A New Paradigm for Innovation



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds